TFLLR-NH2 is a selective PAR1 agonist with an EC50 of 1.9 μM.
CAT No: R1713
CAS No:197794-83-5
Synonyms/Alias:TFLLR-NH2;197794-83-5;Thr-Phe-Leu-Leu-Arg-amide;(2S)-N-[(2S)-1-[[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanamide;H-Thr-Phe-Leu-Leu-Arg-NH2;PAR1-AP;GTPL3742;CHEMBL4065100;L-Argininamide, L-threonyl-L-phenylalanyl-L-leucyl-L-leucyl-;HY-P0226;HB2921;AKOS024456615;CS-6494;TFLLR (modifications: C-terminal amide);AC-32571;AS-76215;DA-48902;FT109632;PEPTIDE1{T.F.L.L.R.[am]}$$$$;(Thr1)-PAR-1 (1-5) amide (human) trifluoroacetate salt;l-threonyl-l-phenylalanyl-l-leucyl-l-leucyl-l-argininamide;(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-phenylpropanamido]-N-[(1S)-1-{[(1S)-4-carbamimidamido-1-carbamoylbutyl]carbamoyl}-3-methylbutyl]-4-methylpentanamide;TFLLRamide, (Thr(1))-TRAP-5 amide, TFLLR-NH2 Protease-Activated Receptor 1 (PAR1) Agonist;(Thr1)-PAR-1 (1-5) amide (human);
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.